Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:51 PM
Ignite Modification Date:
2025-12-24 @ 4:51 PM
NCT ID:
NCT00559650
Eligibility Criteria:
Inclusion Criteria:
* Patients with decompensated chronic congestive heart failure, NYHA functional class III-IV, either ischemic or non-ischemic, requiring hospitalization, and with clinical indication for parenteral pharmacotherapy and invasive hemodynamic monitoring (i.e indwelling Swan-Ganz pulmonary artery catheter) and PCWP \>/= 18 mmHg.
* Patients must have the clinical diagnosis of CHF made at least 3 month prior to enrollment.
* Male or female patients, age 18 years or more.
Exclusion Criteria:
* Females of child-bearing potential.
* Acute de-novo heart failure.
* Acute myocardial infarction and/or myocardial infarction within 30 days.
* Valvular heart disease requiring surgical intervention during the course of the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00559650
Study Brief:
Protocol Section:
NCT00559650